Neurotrophin and neuropeptide expression in mouse brain is regulated by knockout of the norepinephrine transporter

Journal of Neural Transmission

Volumn 115, Issue 7, 2008, Pages 973-982

  Haenisch, B ^a   Gilsbach, R ^a,b   Bonisch H ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

BDNF; CRF; mRNA; NGF; Norepinephrine transporter knockout; NT 3; Protein

Indexed keywords

ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; CORTICOTROPIN RELEASING FACTOR; MESSENGER RNA; NERVE GROWTH FACTOR; NEUROPEPTIDE; NEUROTROPHIN; NEUROTROPHIN 3; NORADRENALIN TRANSPORTER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN STEM; CEREBELLUM; CONTROLLED STUDY; DEPRESSION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HIPPOCAMPUS; KNOCKOUT MOUSE; MOUSE; NONHUMAN; NORADRENALIN RELEASE; NUCLEOTIDE SEQUENCE; OLFACTORY BULB; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; BRAIN; GENE EXPRESSION REGULATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NERVE GROWTH FACTORS; NEUROPEPTIDES; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; RNA, MESSENGER;

EID: 46649105672     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-008-0039-2     Document Type: Article

References (63)

1. Alfonso J, Pollewick GD, van der Hart MG, Flügge G, Fuchs E, Frasch AC (2004) Identification of genes regulated by chronic psychosocial stress and antidepressant treatment in the hippocampus. Eur J Neurosci 19:659-666
2. Altar CA (1999) Neurotrophins and depression. Trends Pharmacol Sci 20:59-61
3. Altar CA, Whitehead RE, Chen R, Wortwein G, Madsen TM (2003) Effects of electroconvulsive seizures and antidepressant drugs on brain-derived neurotrophic factor protein in rat brain. Biol Psychiatry 54:703-709
4. Arenas E, Persson H (1994) Neurotrophin-3 prevents the death of adult central noradrenergic neurons in vivo. Nature 367:368-371
5. Arzt E, Holsboer F (2006) CRF signalling: molecular specificity for drug targeting in the CNS. Trends Pharmacol Sci 27:531-538
6. Bale TL (2006) Stress sensitivity and the development of affective disorders. Horm Behav 50:529-533
7. Berton O, Nestler EJ (2006) New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci 7:137-151
8. Bissette G, Klimek V, Pan J, Stockmeier C, Ordway G (2003) Elevated concentrations of CRF in the locus coeruleus of depressed subjects. Neuropsychopharmacology 28:1328-1335
9. Bönisch H and Brüss M (2006) The norepinephrine transporter in physiology and disease. In: Sitte HH, Freissmuth M (eds) Neurotransmitter transporters, Handbook of experimental pharmacology, vol 175. Springer, Heidelberg, pp 485-524
10. Castren E (2004) Neurotrophic effects of antidepressant drugs. Curr Opin Pharmacol 4:58-64
11. Castren E (2005) Is mood chemistry? Nat Rev Neurosci 6:241-246
12. Chen Y, Bender RA, Frotscher M, Baram TZ (2001) Novel and transient populations of corticotropin-releasing hormone-expressing neurons in developing hippocampus suggest unique functional roles: a quantitative spatiotemporal analysis. J Neurosci 21:7171-7181
13. Chen Y, Brunson KL, Adelmann G, Bender RA, Frotscher M, Baram TZ (2004) Hippocampal corticotropin releasing hormone: pre- and postsynaptic location and release by stress. Neuroscience 126:533-540
14. Coppell AL, Pei QA, Zetterström TSC (2003) Bi-phasic change in BDNF gene expression following antidepressant drug treatment. Neuropharmacology 44:903-910
15. Cryan JF, Holmes A (2005) The ascent of mouse: advantages in modelling human depression and anxiety. Nat Rev Drug Discov 4:775-790
16. Czeh B, Michaelis T, Watanabe T, Frahm J, de Biurrun G, van Kampen M, Bartolomucci A, Fuchs E (2001) Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine. Proc Natl Acad Sci 98:12796-12801
17. de Bellis MD, Gold PW, Geracioti Jr TD, Listwak SJ, Kling MA (1993) Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginine vasopressin in patients with major depression. Am J Psychiatry 150:656-657
18. de Kloet ER, Joels M, Holsboer F (2005) Stress and the brain: from adaptation to disease. Nat Rev Neurosci 6:463-475
19. Duman RS (2004) Role of neurotrophic factors in the etiology and treatment of mood disorders. Neuromolecular Med 5:11-25
20. Duman RS, Heninger GR, Nestler EJ (1997) A molecular and cellular theory of depression. Arch Gen Psychiatry 54:597-606
21. Dziedzicka-Wasylewska M, Faron-Gorecka A, Kusmider M, Drozdowska E, Rogoz Z, Siwanowicz J, Caron MG, Bönisch H (2006) Effect of antidepressant drugs in mice lacking the norepinephrine transporter. Neuropsychopharmacology 31:2424-2432
22. Eisch AJ, Bolanos CA, de Witt J, Simonak RD, Pudiak CM, Barrot M, Verhaagen J, Nestler EJ (2003) Brain-derived neurotrophic factor in the ventral midbrain-nucleus accumbens pathway: a role in depression. Biol Psychiatry 54:994-1005
23. Foreman PJ, Taglialatela G, Angelucci L, Turner PC, Perez-Polo JR (1993) Nerve growth factor and p75 NGFR factor mRNA change in rodent CNS following stress activation of the hypothalamo-pituitary-adrenocortical axis. J Neurosci 36:10-18
24. Gilsbach R, Faron-Gorecka A, Rogoz Z, Brüss M, Caron MG, Dziedzicka-Wasylewska M, Bönisch H (2006a) Norepinephrine transporter knockout-induced up-regulation of brain alpha2A/C-adrenergic receptors. J Neurochem 96:1111-1120
25. Gilsbach R, Kouta M, Bönisch H, Brüss M (2006b) Comparison of in vitro and in vivo reference genes for internal standardization of real-time PCR data. Biotechniques 40:173-177
26. Hashimoto K, Shimizu E, Iyo M (2004) Critical role of brain-derived neurotrophic factor in mood disorders. Brain Res Brain Res Rev 45:104-114
27. Hellweg R, Lang UE, Nagel M, Baumgartner A (2002) Subchronic treatment with lithium increases nerve growth factor content in distinct brain regions of adult rats. Mol Psychiatry 7:604-608
28. Hellweg R Zueger M, Fink K, Hörtnagl H, Gass P (2007) Olfactory bulbectomy in mice leads to increased BDNF levels and decreased serotonin turnover in depression-related brain areas. Neurobiol Dis 25:1-7
29. Hock C, Heese K, Müller-Spahn F, Huber P, Riesen W, Nitsch RM, Otten U (2000) Increased cerebrospinal fluid levels of neurotrophin 3 (NT-3) in elderly patients with major depression. Mol Psychiatry 5:510-513
30. Hofer M, Pagliusi SR, Hohn A, Leibrock J, Barde YA (1990) Regional distribution of brain-derived neurotrophic factor mRNA in the adult mouse brain. EMBO J 9:2459-2464
31. Holsboer F (2003) Corticotropin-releasing hormone modulators and depression. Curr Opin Investig Drugs 4:46-50
32. Ising M, Zimmermann US, Künzel HE, Uhr M, Foster AC, Learned-Coughlin SM, Holsboer F, Grigoriadis DE (2007) High-affinity CRF1 receptor antagonist NBI-34041: Preclinical and clinical data support safety and efficacy in attenuating elevated stress response. Neuropsychopharmacology 32:1941-1949
33. Ivy AS, Rodriguez FG, Garcia C, Chen MJ, Russo-Neustadt AA (2003) Noradrenergic and serotoninergic blockade inhibits BDNF mRNA activation following exercise and antidepressants. Pharmacol Biochem Behav 75:81-88
34. Katoh-Semba R, Takeuchi IK, Semba R, Kato K (1997) Distribution of brain-derived neurotrophic factor in rats and its changes with the development in the brain. J Neurochem 69:34-42
35. Keck ME, Ohl F, Holsboer F, Müller M (2005) Listening to mutant mice: a spotlight on the role of CRF/CRF receptor systems in affective disorders. Neurosci Biobehav Rev 29:867-889
36. Kim SJ, Park SH, Choi SH, Moon BH, Lee KJ, Kang SW, Lee MS, Choi SH, Chun BG, Shin KH (2006) Effects of repeated tianeptine treatment on CRF mRNA expression in non-stressed and chronic mild stress-exposed rats. Neuropharmacology 50:824-833
37. Levi-Montalcini R, Skaper SD, Toso RD, Petrelli L, Leon A (1996) Nerve growth factor: from neurotrophin to neurokine. Trends Neurosci 19:514-520
38. Lorang D, Amara SG, Simerly RB (1994) Cell-type-specific expression of catecholamine transporters in the rat brain. J Neurosci 14:4903-4914
39. Maisonpierre PC, Belluscio L, Friedman B, Alderson RF, Wiegand SJ, Furth ME, Lindsay RM, Yancopoulos GD (1990) NT-3, BDNF, and NGF in the developing rat nervous system: parallel as well as reciprocal patterns of expression. Neuron 5:501-509
40. Malberg JE, Eisch AJ, Nestler EJ, Duman RS (2000) Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 20:9104-9110
41. Malberg JE, Blendy JA (2005) Antidepressant action: to the nucleus and beyond. Trends Pharmacol Sci 26:631-638
42. Manji HK, Quiroz JA, Sporn J, Payne JL, Denicoff K, Gray NA, Zarate CA, Charney DS (2003) Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression. Biol Psychiatry 53:707-742
43. Nakane T, Audhya T, Hollander CS, Schlesinger DH, Kardos P, Brown C, Passarelli J (1986) Corticotrophin-releasing factor in extra-hypothalamic brain of the mouse: demonstration by immunoassay and immunoneutralization of bioassayable activity. J Endocrinol 111:143-149
44. Nestler EJ, Barrot M, DiLeone RJ, Eisch A, Gold SJ, Monteggia LM (2002) Neurobiology of depression. Neuron 34:13-25
45. Nibuya M, Morinobu S, Duman RS (1995) Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 15:7539-7547
46. Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45
47. Post RM (2007) Role of BDNF in bipolar and unipolar disorder: clinical and theoretical implications. J Psychiatr Res 41:979-990
48. Reul JM, Holsboer F (2002) Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression. Curr Opin Pharmacol 2:23-33
49. Risbrough VB, Stein MB (2006) Role of corticotropin releasing factor in anxiety disorders: a translational research perspective. Horm Behav 50:550-561
50. Russo-Neustadt AA, Alejandre H, Garcia C, Ivy AS, Chen MJ (2004) Hippocampal brain-derived neurotrophic factor expression following treatment with reboxetine, citalopram, and physical exercise. Neuropsychopharmacology 29:2189-2199
51. Rylett RJ, Williams LR (1994) Role of neurotrophins in cholinergic-neuron function in the adult and aged CNS. Trends Neurosci 17:486-490
52. Scaccianoce S, Lombardo K, Angelucci L (2000) Nerve growth factor brain concentration and stress changes depend on type of stressor and age. Int J Dev Neurosci 18:469-479
53. Schulte-Herbrüggen O, Chourbaji S, Müller H, Danker-Hopfe H, Brandwein C, Gass P, Hellweg R (2006) Differential regulation of nerve growth factor and brain-derived neurotrophic factor in a mouse model of learned helplessness. Exp Neurol 202:404-409
54. Shirayama Y, Chen AC, Nakagawa S, Russell DS, Duman RS (2002) Brain-derived neurotrophic factor produces antidepressant effects in behavioural models of depression. J Neurosci 22:3251-3261
55. Smith MA, Makino S, Altemus M, Michelson D, Hong SK, Kvetnansky R, Post RM (1995) Stress and antidepressants differentially regulate neurotrophin 3 mRNA expression in the locus coeruleus. Proc Natl Acad Sci 92:8788-8792
56. Spillantini MG, Aloe L, Alleva E, De Simone R, Goedert M, Levi-Montalcini R (1989) Nerve growth factor mRNA and protein increase in hypothalamus in a mouse model of aggression. Proc Natl Acad Sci 86:8555-8559
57. Stout SC, Owens MJ, Nemeroff CB (2002) Regulation of corticotropin- releasing factor neuronal systems and hypothalamic-pituitary-adrenal axis activity by stress and chronic antidepressant treatment. J Pharmacol Exp Ther 300:1085-1092
58. von Richthofen S, Lang UE, Hellweg R (2003) Effects of different kinds of acute stress on nerve growth factor content in rat brain. Brain Res 987:207-213
59. Wang YM, Xu F, Gainetdinov RR, Caron MG (1999) Genetic approaches to studying norepinephrine function: knockout of the mouse norepinephrine transporter gene. Biol Psychiatry 46:1124-1130
60. Whittemore SR, Ebendal T, Lärkfors L, Olson L, Seiger A, Strömberg I, Persson H (1986) Developmental and regional expression of ß nerve growth factor messenger RNA and protein in the rat central nervous system. Proc Natl Acad Sci 83:817-821
61. Willner P (1990) Animal models of depression: an overview. Pharmacol Ther 45:425-455
62. Xu F, Gainetdinov RR, Wetsel WC, Jones SR, Bohn LM, Miller GW, Wang YM, Caron MG (2000) Mice lacking the norepinephrine transporter are supersensitive to psychostimulants. Nat Neurosci 3:465-471
63. Zhang JM, Dix J, Langtimm-Sedlack CJ, Trusk T, Schroeder B, Hoffmann R, Strosberg AD, Winslow JW, Sieber-Blum M (1997) Neurotrophin-3- and norepinephrine-mediated adrenergic differentiation and the inhibitory action of desipramine and cocaine. J Neurobiol 32:262-280